Our Mission:

To Rid the World of Obstructive Sleep Apnea

Differentiated Products
FDA Registrations and Clearances since 2009
Vivos System Insurance Reimbursement
Extensive Training and Support Systems

We are a medical technology company focused on the development and commercialization of innovative solutions for patients with sleep disordered breathing (SDB), including obstructive sleep apnea (OSA). We develop and market a number of specially-designed, customized and pre-formed oral appliances, which are integrated into a patient-specific, multi-disciplinary clinical protocol that is used by trained dental and medical providers to address certain craniofacial conditions associated with SDB and OSA. We refer to our proprietary and novel combination of products and protocols as the Vivos System. Our clinical education and training is delivered via online and in-person training through our Institute for Craniofacial Sleep Medicine.

The Vivos System combines both patented and proprietary technologies that induce the remodeling of hard and soft tissues of the human airway – a process that we believe opens airway space and can eliminate or significantly reduce symptoms and conditions associated with OSA. The Vivos System technology represents the first non-surgical, non-invasive and cost-effective solution for the hundreds of millions of people globally who suffer from OSA. The Vivos System combines a customized oral appliance with a propriety therapeutic protocol to gently remodel and enhance the size, shape, and function of the airway by mimicking biological processes (a process known as biomimetics). The Vivos System has been shown to significantly lower Apnea Hypopnea Index (or AHI) scores and improve other conditions associated with OSA. Our patented oral appliances have proven effective (within the scope of the U.S. Food and Drug Administration (or FDA) cleared uses as described below) in over 15,000 patients successfully treated worldwide by more than 1,200 trained dentists.

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign Up Now

Latest Stock Information

Investor Presentation

Download the Vivos Investor Presentation.

Download Now

Latest SEC Filings

Vivos Therapeutics Launches AireO2 Patient Management Technology to Treat Patients with Obstructive Sleep Apnea

Obstructive Sleep Apnea is One of the Most Prevalent Diseases in the World, Affecting Approximately 1 Billion People and Contributing to Serious Comorbidities

Read The Story

Corporate Leadership

Our leadership team is devoted to a singular mission - to rid the world of sleep apnea.

18,000

Over 18,000 Patients Treated

1,200

Doctors Integrated + Trained

1

Over 1B Potential Patients

Investor Relations Contacts

Home Office

Vivos Therapeutics, Inc.
(866) 908-4867
9135 S Ridgeline Blvd
Suite 100
Highlands Ranch, CO
80129

Capital Markets

Edward Loew
SVP, Capital Markets
(602) 903-0095
9137 S Ridgeline Blvd
Suite 135
Highlands Ranch, CO
80129

Investor Relations

Phil Carlson / Scott Eckstein
KCSA Strategic Communications
212-896-1210
[email protected]

Transfer Agent

Vstock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: 212.828.8436
Fax: 646-536-3179
Email: [email protected]